QIAGEN (QGEN)
(Delayed Data from NYSE)
$49.95 USD
-0.30 (-0.60%)
Updated Aug 5, 2025 04:00 PM ET
Pre-Market: $49.95 0.00 (0.00%) 9:20 AM ET
2-Buy of 5 2
C Value B Growth C Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
For QIAGEN N.V., the company has a dividend yield of 0.50% compared to the Medical - Biomedical and Genetics industry's median yield of zero percent.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
QGEN 49.95 -0.30(-0.60%)
Will QGEN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for QGEN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for QGEN
Qiagen (QGEN) Reports Q2 Earnings: What Key Metrics Have to Say
Qiagen (QGEN) Matches Q2 Earnings Estimates
QGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
CERVOMED INC (CRVO) Surges 11.6%: Is This an Indication of Further Gains?
Why Qiagen (QGEN) is a Top Growth Stock for the Long-Term
Is Hologic Stock a Risky Investment Ahead of Its Q3 Earnings Report?
Other News for QGEN
Here are the major earnings after the close Tuesday
What to Expect from Qiagen NV (QGEN) Q2 2025 Earnings
Qiagen Non-GAAP EPS of $0.60 in-line, revenue of $534M beats by $9.98M
QIAGEN (QGEN) Exceeds Q2 Revenue Expectations, Prepares for New Launches
Earnings Scheduled For August 5, 2025